This company has been marked as potentially delisted and may not be actively trading. NYSE:IMPR Imprivata (IMPR) Stock Price, News & Analysis Add Share Share Stock Analysis Stock AnalysisBuy This Stock About Imprivata Stock (NYSE:IMPR) 30 days 90 days 365 days Advanced Chart Get Imprivata alerts:Sign Up Key Stats Today's Range$19.26▼$19.2650-Day Range N/A52-Week Range$9.00▼$20.32VolumeN/AAverage Volume258,396 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewImprivata, Inc. (Imprivata) is a United States-based healthcare information technology security company. The Company enables healthcare organizations to access, communicate and transact patient information securely. The Company offers Imprivata OneSign, Imprivata Cortext, Imprivata Confirm ID and Imprivata PatientSecure. Imprivata OneSign provides single sign-on, authentication management and virtual desktop roaming, enabling No Click Access to clinical applications and patient information, anytime, anywhere and from any device. Imprivata Cortext enables clinicians to collaborate across care teams and organizations. Imprivata Confirm ID is an identity and two-factor authentication platform for remote access, electronic prescriptions for controlled substances (EPCS), medical device access and other clinical authentication workflows. Imprivata PatientSecure is a patient identification solution that uses palm vein recognition biometrics to identify patients at any point of entry to care.Read More… Receive IMPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Imprivata and its competitors with MarketBeat's FREE daily newsletter. Email Address IMPR Stock News HeadlinesDHA strengthens patient data security with NABIDH initiativeApril 27 at 12:33 PM | msn.comImprivata Introduces New Advanced Analytics Solution to Deliver Key Security and Operational Insights into Enterprise Mobile Device UsageApril 9, 2025 | finance.yahoo.comHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.April 29, 2025 | Brownstone Research (Ad)Over Half of UK Organisations Experienced a Security Breach Resulting from Third-Party Access in the Past Year, Imprivata Study FindsMarch 11, 2025 | finance.yahoo.comImprivata Study Finds Nearly Half of Organizations Suffered a Third-Party Security Incident in Past YearFebruary 13, 2025 | markets.businessinsider.comImprivata Enterprise Access Management Wins 2025 Best in KLAS Award for Access ManagementFebruary 5, 2025 | finance.yahoo.comTax incentives announced for life science companies in Mass.October 15, 2024 | msn.comHealthcare’s Password Problem And How To Fix ItOctober 8, 2024 | forbes.comSee More Headlines IMPR Stock Analysis - Frequently Asked Questions How were Imprivata's earnings last quarter? Imprivata, Inc. (NYSE:IMPR) posted its quarterly earnings results on Tuesday, February, 16th. The technology company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.10) by $0.01. The business's quarterly revenue was up 17.9% compared to the same quarter last year. What other stocks do shareholders of Imprivata own? Based on aggregate information from My MarketBeat watchlists, some other companies that Imprivata investors own include BioCryst Pharmaceuticals (BCRX), Teledyne FLIR (FLIR), Allegion (ALLE), Anixter International (AXE), Avigilon (AVO), Ascent Capital Group Inc Series A (ASCMA) and ASSA ABLOY AB (publ) (ASAZY). Company Calendar Last Earnings2/16/2016Today4/29/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:IMPR CIK1328015 Webwww.imprivata.com Phone+1-781-6742700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NYSE:IMPR) was last updated on 4/29/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imprivata, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Imprivata With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.